Skip to content

Aromatherapy Treatment With Lavender Essential Oil to Reduce Post-Operative Nausea and Vomiting (PONV)

Evaluation of the Efficacy of an Aromatherapy Treatment With Lavender Essential Oil to Reduce Post-Operative Nausea and Vomiting (PONV): Two-arm, Non-pharmacological, Single-centre, Non-profit, Randomised Controlled Trial

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07176676
Acronym
Leo-PONV
Enrollment
128
Registered
2025-09-16
Start date
2022-11-15
Completion date
2025-12-15
Last updated
2025-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PONV

Keywords

nausea, vomit, lavanda, Postoperative

Brief summary

The aim of this study is to evaluate the effectiveness of aromatherapy through the use of inhaled Lavender oil in reducing patients' nausea during the post-operative period.

Detailed description

To evaluate the effectiveness of inhaling Lavender Angustifolia essential oil in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative period. Secondary objective * To detect the number of antiemetic administrations in the experimental arm compared to the control arm * To measure the patient satisfaction of patients in the experimental group with the Lavender essential oil aromatherapy intervention at hospital discharge Primary endpoint Reduction of nausea by at least 10% compared to treatment with standard care, as assessed by the NRS (Numerical Rating Scale).

Interventions

OTHERLavanda Angustifolia essential oil

Administration of Lavender Angustifolia essential oil by inhalation in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative period.

OTHERUsual Care

Patients in the Usual Care group will follow the standard procedure, which consists of administering antiemetics if provided in therapy or reporting to the doctor with a subsequent treatment decision

Sponsors

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Non-pharmacological, single-centre, non-profit, randomised controlled trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who sign an informed consent * Patients who have undergone anesthesiological examination * Patients undergoing general anaesthesia * Clinically stable patients * Patients with nausea scores detected with NRS\>0 * Patients admitted undergoing surgery in the Complex and/or Simple Structures listed below: * SC of Neurosurgery, undergoing spinal surgery * SC of General Surgery, undergoing surgery on one of the organs of the abdominal cavity * SC of Vascular Surgery, undergoing traditional surgical repair or endovascular procedure of abdominal aortic aneurysm. Sclerotherapy (to heal varicose veins) venous stripping (removal of a vein segment in the treatment of varicose veins) laser treatment * SS of Gynaecological Surgery, undergoing operations on the organs of the female genital apparatus.

Exclusion criteria

Patients with ongoing relevant cognitive impairment (Six Item Screener score \<4) * Patients with allergies or sensitivities to lavender essential oils * Patients with asthma, COPD, Chronic Bronchitis, Obstructive Sleep Apnea * Patients with changes in sense of smell

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the effectiveness of administering Lavender Angustifolia essential oil by inhalation in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative periodduring the 24-hour post-operative periodTo reduce nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative period. Endpoint Reduction of nausea by at least 10% compared to treatment with standard care, as assessed by the NRS (Numerical Rating Scale).

Secondary

MeasureTime frameDescription
To evaluate the effectiveness of administering Lavender Angustifolia essential oil by inhalation in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative periodduring the 24-hour postoperative periodTo measure the number of antiemetic administrations in the experimental arm compared to the control arm
o evaluate the effectiveness of administering Lavender Angustifolia essential oil by inhalation in reducing nausea after abdominal, vascular, neurosurgical and gynaecological surgery under general anaesthesia during the 24-hour postoperative periodduring the 24-hour postoperative periodTo measure the patient satisfaction of the patients in the experimental group regarding the aromatherapy intervention with Lavender essential oil at hospital discharge

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026